A  Mid Atlantic Bio Angels


     Office Locations:

New York, NY



  • Seed



  • Life Sciences & Healthcare



    Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies. Membership in MABA is by invitation only, and is extended to active, accredited investors (life science angels) who wish to make investments in life science companies, as well as institutional investors and life science company venture arms wishing to invest alongside the angels. MABA places no geographical restrictions or requirements for presenting companies and invests primarily in pharmaceuticals, health devices, and health apps. Entrepreneurs can apply to pitch to MABA, and some of the 60 members may invest together to create a funding round of up to $500,000. MABA is not a fund and its members invest as individuals or as a group - at their discretion, or as arranged with the company receiving the investment.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bernard Rudnick Co-Founder
    Stephen Goodman Co-Founder
    Yaniv Sneor Co-Founder


    Portfolio companies include:

      Cerus Endovascular
        web link

      Immunomic Therapeutics
        web link


    Recent News: